TTO Flanders Pitch Session

This session is supported by Kadans Science Partner, who focus on the development and operation of industrial and office buildings, in combination with laboratories, cleanrooms, research facilities, climate-controlled spaces and pilot plants for R&D departments of knowledge institutions, education institutes and knowledge-intensive businesses.

TTO Flanders is a joint initiative of the five Flemish universities: Ghent University, University of Antwerp, KU Leuven, Vrije Universiteit Brussel and Hasselt University. The technology transfer offices (TTOs) of these universities are responsible for the transfer of knowledge and technology from universities and associated university colleges to private and public partners.

In this session, moderator Lieve Hoflack, welcomes five researchers, each representing one of the five universities. They'll be talking about:

• SCREEN4PN, an iPSC testing platform being developed to efficiently test new therapeutic compounds for CMT disease - (Tamira van Wermeskerken, University of Antwerp)
• The making of a Belgian universal SARS-CoV-2 mRNA vaccine - (Niek Sanders, Ghent University)
• MighTy, a KU Leuven spin-off incubation project of the Laboratory for Therapeutic and Diagnostic Antibodies and of PharmAbs, the KU Leuven Antibody Center - (Nick Geukens, KU Leuven)
• Why a 3R Innovation Centre is necessary - (Robim Rodrigues, VUB)
• Using multicolour flow cytometry and clustering analysis to detect T cell responses to vaccination in non-responders - (Niels Hellings, Hasselt University)